Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dycnos-AQ Injection

Prescription Icon
Prescription Required

Marketer

Ridgecure Pharma

Salt Composition

Diclofenac (75mg)

Overview Dycnos-AQ Injection

Aquodyne injection provides pain relief and manages inflammation, stiffness, and joint pain associated with conditions such as rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral medication is infeasible. This injectable medication must be administered by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Common adverse effects include nausea, vomiting, headache, and local injection site reactions. For prolonged therapy, regular monitoring of renal and hepatic function, along with blood counts, is recommended. Extended use may increase the risk of serious complications, including gastrointestinal bleeding and renal impairment.

Primary Ingredients of Dycnos-AQ Injection

No text provided to rephrase.

Uses of Dycnos-AQ Injection

Analgesia

Major Benefits of Dycnos-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Dycnos-AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Dycnos-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Dycnos-AQ Injection works:

Dycnos-AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of specific inflammatory mediators responsible for pain and the associated symptoms of redness and swelling.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when drinking alcohol while receiving Dycnos-AQ Injection. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Dycnos-AQ Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Dycnos-AQ Injection while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administration of Dycnos-AQ Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Administering Dycnos-AQ Injection to individuals with impaired renal function requires careful monitoring. Dosage modification of Dycnos-AQ Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when administering Dycnos-AQ Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dycnos-AQ Injection :

Omit a Dycnos-AQ Injection dose? Seek medical advice immediately.

Facts to Know About Dycnos-AQ Injection

LabelValue
Chemical Category Phenylacetic Acid Analog
Developing Good Habits No.
Treatment Category Pain Relievers

FAQs on Dycnos-AQ Injection

Dycnos-AQ Injection must be administered only by a healthcare professional. Intramuscular (preferably in the buttock), subcutaneous, or intravenous bolus injection is acceptable; however, intravenous infusion is contraindicated. The prescribed dose must not be exceeded, and treatment should not extend beyond two days.
Dycnos-AQ Injection may increase your risk of heart attack or stroke, particularly with higher doses or prolonged use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially fatally and without warning, at any time. Seek immediate medical attention if you experience any such symptoms.
Dycnos-AQ Injection provides effective pain and inflammation relief. Its applications include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Prolonged use or high doses of Dycnos-AQ Injection can lead to kidney issues, potentially manifesting as proteinuria, hematuria, or dysuria. Individuals at increased risk of kidney complications—including those who are dehydrated, have heart failure, pre-existing kidney impairment, hypertension, are elderly, or take diuretics or nephrotoxic medications—should undergo regular kidney function monitoring.
Dycnos-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon. If you experience any of these, refrain from driving or operating machinery.
Avoid Dycnos-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature labor. Its use should also be avoided during the first six months. Use in pregnancy should only be considered if the potential benefits clearly outweigh the risks. Always consult your doctor before using Dycnos-AQ Injection if you are pregnant.
Dycnos-AQ Injection is not a recreational drug; it has no potential for abuse or dependence. If you experience any adverse effects, seek medical advice.
Dycnos-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Dycnos-AQ Injection
17
MRP 20
15% off